Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Clofarabine × Myeloid × Clear all

Phase

Status

Sponsor Class

OTHER 31 INDUSTRY 3 NIH 2 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Lymphoid 2 Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Blast Crisis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00098033 2015-03-25

Investigation of Clofarabine in Acute Leukemias

FDA Office of Orphan Products Development

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡